Chinese Medicine Regulatory Office
Site Menu
Notices
For latest Government press release, you may visit the HKSAR website.
- Consultation on amendments to the limits for harmful residues in Chinese herbal medicines in Hong Kong commences(31 March 2021)
- Letter to Chinese medicine practitioner: COVID-19 - Local epidemic situation and latest arrangements of vaccination programme (Chinese version only) (16 March 2021)
- The 81st to 90th monographs of project “Identification of Easily Confused Species of Chinese Materia Medica in Hong Kong by Macroscopic and Microscopic Characteristics” have been published in March 2021 (10 March 2021)
- Letter to Chinese medicine practitioner: COVID-19 - Latest situation and vaccination arrangement (Chinese version only) (22 February 2021)
- DH endorses batch recall of mercury-tainted proprietary Chinese medicine (with photo)(3 February 2021)
- Letter to Chinese medicine practitioner: COVID-19 - Ongoing epidemic (Chinese version only) (27 January 2021) Letter | Appendix
- Results of Hong Kong Chinese Materia Medica Standards (Phase X) announced (22 December 2020)
- Department of Health mounts joint operation with Hong Kong Customs and investigates a case involving Chinese medicine granules for prescription with suspected false claim (with photo) (18 December 2020)
- Letter to Chinese medicine practitioner: COVID-19 - A surge of local cases and new round of anti-epidemic measures (Chinese version only) (17 December 2020) Letter | Appendix
- The 71st to 80th monographs of project “Identification of Easily Confused Species of Chinese Materia Medica in Hong Kong by Macroscopic and Microscopic Characteristics” have been published in December 2020(2 December 2020)
- List of proprietary Chinese medicines with label or package insert not complied with the Chinese Medicines Regulation (3 November 2020)
- DH investigates case of undeclared Western drug ingredients detected in cream products prescribed by registered Chinese medicine practitioner (with photo) (2 November 2020)
- New analytical methods of project “Analysis of Cornu Cervi Pantotrichum by DNA Method as a Complementary Approach” have been published in November 2020 (2 November 2020)
- New analytical methods of project “Reference DNA Sequence Library for Chinese Materia Medica (CMMRSL)” have been published in November 2020 (2 November 2020)
- Letter to Wholesalers of Proprietary Chinese Medicines from Department of Health: Import and Export of Proprietary Chinese Medicines (Chinese version only) (6 October 2020)
- Letter to Wholesalers of Chinese Herbal Medicines from Department of Health: Import and Export of Proprietary Chinese Medicines and Chinese Herbal Medicines and Sale of Chinese Herbal Medicines via the Internet (Chinese version only) (6 October 2020)
- Letter to Retailers of Chinese Herbal Medicines from Department of Health: Import and Export of Proprietary Chinese Medicines and Chinese Herbal Medicines and Sale of Chinese Herbal Medicines via the Internet (Chinese version only) (6 October 2020)
- Recall of Chinese medicine granules with failed microbial limit (with photo) (28 September 2020)
- The 61st to 70th monographs of project “Identification of Easily Confused Species of Chinese Materia Medica in Hong Kong by Macroscopic and Microscopic Characteristics” have been published in September 2020(8 September 2020)
- List of proprietary Chinese medicines with label or package insert not complied with the Chinese Medicines Regulation (4 September 2020)
- Letter to Chinese medicine practitioner: COVID-19 - Universal Community Testing Programme (Chinese version only) (31 August 2020)
- New analytical methods of project “Analysis of Cornu Cervi Pantotrichum by DNA Method as a Complementary Approach” have been published in August 2020 (21 Aug 2020)
- DH investigates case of undeclared Western drug ingredients detected in cream products prescribed by registered Chinese medicine practitioner (7 August 2020)
- Letter to Chinese medicine practitioner: COVID-19 - Enhanced anti-epidemic measures (Chinese version only) (28 July 2020)
- Letter to Chinese medicine practitioner: COVID-19 - A surge of local cases and new round of anti-epidemic measures (Chinese version only) (20 July 2020)
- DH investigates case of undeclared Western drug ingredients detected in powder prescribed by listed Chinese medicine practitioner (20 July 2020)
- Letter to Chinese medicine practitioner: COVID-19 - A surge of local cases and new round of anti-epidemic measures (Chinese version only) (15 July 2020)
- Letter to Chinese medicine practitioner: COVID-19 - New Local Cases Emerging (Chinese version only) (10 July 2020) Letter | Appendix
- DH investigates case of undeclared Western drug ingredient detected in cream product prescribed by registered Chinese medicine practitioner (6 July 2020)
- List of proprietary Chinese medicines with label or package insert not complied with the Chinese Medicines Regulation (18 June 2020)
- Letter to Chinese medicine practitioner: COVID-19 – A new cluster of local cases, expansion of "Enhanced Laboratory Surveillance Programme", and “Special Chinese Medicine Out-patient Programme” of the Hospital Authority (Chinese version only) (3 June 2020)
- New analytical methods of project “Analysis of Chemical Markers of Chinese Materia Medica (CMM) in Medicinal Oil for External Use” have been published in May 2020 (22 May 2020)
- CHP investigates suspected poisoning case after consumption of medicinal plant (8 May 2020)
- Letter to Chinese medicine practitioner: Enhanced anti-epidemic measures for COVID-19 (Chinese version only) (6 April 2020)
- Letter to Chinese medicine practitioner: Enhanced anti-epidemic measures for COVID-19 (Chinese version only) (25 March 2020)
- Letter to Chinese medicine practitioner: COVID-19 - Further extension of health quarantine arrangements on inbound travellers from overseas (Chinese version only) (18 March 2020)
- Letter to Chinese medicine practitioner: COVID-19 - updated health quarantine arrangements on inbound travellers from overseas (Chinese version only) (16 March 2020)
- Letter to Chinese medicine practitioner: Update on Countries/Areas with Reported Cases of COVID-19 (Chinese version only) (11 March 2020)
- Letter to Chinese medicine practitioner: Latest Information on COVID-19 and Enhanced Surveillance on Suspected Cases by the Centre for Health Protection (Chinese version only) (3 March 2020)
- Letter to Chinese medicine practitioner: Latest Information on COVID-19 and "Enhanced Laboratory Surveillance Programme" by the Hospital Authority (Chinese version only) (25 February 2020) Letter | Appendix
- Letter to Chinese medicines practitioner: Latest Information on Novel Coronavirus Infection (Chinese version only) (10 February 2020)
- Letter to retailers of Chinese herbal medicines from Department of Health on "Supplies for maintaining good personal and environmental hygiene"(Chinese version only) (3 February 2020)
- Letter to Chinese medicines practitioner: Latest Information on Cluster of Pneumonia Cases in Wuhan (Chinese version only) (31 January 2020)
- Hong Kong enters winter influenza season (9 January 2020)
- Letter to Chinese medicines practitioner: Latest Information on Cluster of Pneumonia Cases in Wuhan (Chinese version only) (8 January 2020)
- Letter to Chinese medicines practitioner: Latest Information on Cluster of Pneumonia Cases in Wuhan (Chinese version only) (4 January 2020)
- Letter to Chinese medicines practitioner: Cluster of Pneumonia Cases in Mainland China(Chinese version only) (2 January 2020)
Latest Activities
- The roving exhibition on Chinese medicine will be held on 29 June-2 July 2020 at Nan Fung Plaza in Tseung Kwan O (24 June 2020)
- The roving exhibition on Chinese medicine will be held on 22-25 June 2020 at Cheung Fat Plaza in Tsing Yi (19 June 2020)